Traders Alert: HollyFrontier Corp, Saks Inc., Zynga Inc., Cord Blood America Inc.

Lakeway, TX -- (SBWIRE) -- 02/26/2013 -- vb-news.net, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

HollyFrontier Corp (NYSE:HFC) declined 4.45% to $52.17 on a traded volume of 976k shares. The Company reported fourth quarter net income of $391.6 million or $1.92 per diluted share compared to $223.4 million or $1.06 per diluted share in the quarter ended December 31, 2011. Refinery gross margins were $24.00 per produced barrel, a 57% increase compared to $15.32 for the fourth quarter of 2011. Production levels averaged approximately 447,000 barrels per and crude oil charges averaged approximately 408,000 BPD for the current quarter compared to expected crude throughput of 424,000 BPD.

How Should Investors Trade HFC After The Solid Jump? Let’s Find Out Here

Saks Inc. (NYSE:SKS) went up 0.27% to $11.07. The Company reported fourth quarter EPS of $0.17, above the analyst estimate of $0.15. Revenue for the quarter was $976.6 million versus the consensus estimate of $963.14 million. The fourth quarter total sales increased 1.0% and comparable store sales increased 0.7%.

Is SKS Ready To Jump Again After The Solid Momentum? Get Free Trend Analysis Here

Zynga Inc. (NASDAQ:ZNGA) went down 0.15% to $3.40 on a traded volume of 1.02 million shares. So far this year, the stock is up over 45%. The 52-week range for the stock is $2.09 and $15.91. The Company will close four offices and lay off about 30 people as it continues to cut costs and consolidate after three straight quarters of shrinking revenue and amid concerns about its ability to turn a profit.

Is ZNGA Buy After The Recent Price Movement? Find Out Here

Cord Blood America Inc. (OTC: CBAI) soared 12.50% to $0.0045 on a traded volume of 7.90 million shares. So far this year, the stock is down over 10%. The 52-week range for the stock is $0.0 and $0.03. Cord Blood America, Inc. is a holding company. CBAI is primarily an umbilical cord blood stem cell preservation company, with a particular focus on the acquisition of customers in need of family based products and services.

Is CBAI a Buy At The Current Market Price? Don’t Miss Out Our Special Coverage Here

About vb-news.net
vb-news.net’s team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by vb-news.net is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. vb-news.net does expect that investors will buy and sell securities based on information assembled and presented in vb-news.net. PLEASE always do your own due diligence, and consult your financial advisor.